<?xml version="1.0" encoding="UTF-8"?>
<results title="testTrace">
 <result pre="implemented aggressive public health measures â€&quot; including the enforcement of" exact="social distancing" post="and total lockdowns, aiming to limit the transmission of"/>
 <result pre="definitive conclusion as to the most safe and effective COVID-19" exact="treatment" post="option. The ongoing large-scale trials on the potential treatments"/>
 <result pre="potential activity against SARS-CoV-2a Lopinavir/ritonavir (LPV/r)Approved drug combination for HIV" exact="infection" post="A fixed dose combination medication indicated for the treatment"/>
 <result pre="HIV infection A fixed dose combination medication indicated for the" exact="treatment" post="and prevention of HIV/AIDS (HIV-1 Protease inhibitor) â€¢In vitro"/>
 <result pre="vitro and animal studies demonstrated LPV/r activity against/benefit for the" exact="treatment" post="of MERS-CoV 2,9,10 but more study is need on"/>
 <result pre="median duration of viral shedding was shorter in the LPV/r" exact="treatment" post="group (nÂ =Â 78) than that in no LPV/r"/>
 <result pre="treatment group (nÂ =Â 78) than that in no LPV/r" exact="treatment" post="group (nÂ =Â 42) (median, 22 days vs 28.5"/>
 <result pre="28.5 days, pÂ =Â 0.02). Only earlier administration of LPV/r" exact="treatment" post="(â‰¤10 days from symptom onset) could shorten the duration"/>
 <result pre="patients (nÂ =Â 199) hospitalised with severe COVID-19 demonstrated LPV/r" exact="treatment" post="did not significantly accelerate clinical improvement, reduce mortality, or"/>
 <result pre="LPV/r (alone or in combination with other antivirals) for COVID-19" exact="treatment" post="is accumulating,16, 17, 18 there is a need for"/>
 <result pre="metabolised by CYP3A and CYP2C19 RemdesivirExperimental drug for Ebola virus" exact="infection" post="A broad-spectrum antiviral agent (investigational nucleoside analogue that may"/>
 <result pre="the clinically achievable concentration in humans reduced mortality following SARS-CoV" exact="infection" post="from 100% to 30â€&quot;35%. â€¢In vitro studies demonstrated that"/>
 <result pre="inhalation (nÂ =Â 45) in COVID-19 patients showed significantly better" exact="treatment" post="effects of FPV in terms of disease progression and"/>
 <result pre="superinfection. â€¢It has been used as adjunct therapy in the" exact="treatment" post="of viral respiratory tract infections such as influenza,28,29 albeit"/>
 <result pre="pharmacokinetics and toxicity profile of chloroquine is well-established in malaria" exact="treatment" post="(the use of high dose for short period or"/>
 <result pre="â€¢A randomized, controlled open-label trial compared the efficacy of standard" exact="treatment" post="(oxygen therapy, antiviral agents, antibacterial agents, and immunoglobulin, with"/>
 <result pre="antibacterial agents, and immunoglobulin, with or without corticosteroids) vs standard" exact="treatment" post="plus oral hydroxychloroquine in patients in COVID-19 patients (nÂ"/>
 <result pre="or harm of these drugs in COVID-19 infection. Continuation of" exact="treatment" post="with ACE inhibitors or ARBs is recommended for patients"/>
 <result pre="(inhaled) A selective pulmonary vasodilator with demonstrated benefit in the" exact="treatment" post="of acute respiratory distress syndrome (ARDS), one of the"/>
 <result pre="(oseltamivir)57 are currently under investigation for potential use in the" exact="treatment" post="of COVID-19. bOther drugs currently being evaluated for potential"/>
 <result pre="â€˜infodemicâ€™ â€&quot; parallel global emergencies Although there is no approved" exact="treatment" post="for COVID-19, nearly 800 clinical trials have been registered"/>
 <result pre="cases and deaths).60 Also, reports of distribution of faulty coronavirus" exact="testing" post="kits and substandard protective gears have dominated the news"/>
 <result pre="of the pandemic, symptoms, mode of transmission, promoting prevention and" exact="infection" post="control procedures in line with the public health guidelines."/>
 <result pre="differentiate these symptoms from seasonal influenza is instrumental in early" exact="detection" post="and referrals for further assessment, as required. This involves"/>
 <result pre="capabilities to reduce the burden on general practitioners and support" exact="social distancing" post="and self-isolation measures employed by the authorities. National, state"/>
 <result pre="in liaison with their medical practitioner. In order to promote" exact="social distancing" post="and self-isolation especially in vulnerable patients, home delivery services"/>
 <result pre="identifying, preventing and treating medication-related problems71 managing minor ailments,72 early" exact="detection" post="and appropriate referral of possible cases of the COVID-1973,"/>
 <result pre="therapeutic measures. â€¢Counsel communities on therapy and medications for the" exact="treatment" post="of minor symptoms associated with COVID-19. â€¢Guide the public"/>
 <result pre="channels within each country. â€¢Participate actively in COVID-19 hygiene and" exact="infection" post="control initiatives or strategies. â€¢Conduct health-education campaigns that promote"/>
 <result pre="disease 2019 (COVID-19)J Gen Intern Med20201531625040 2CascellaM.RajnikM.CuomoA.DulebohnS.C.Di NapoliR.Features, evaluation and" exact="treatment" post="coronavirus (COVID-19)StatPearls2020StatPearls Publishing[Internet] 3COVIDC.Severe outcomes among patients with coronavirus"/>
 <result pre="April 2020271280e832142651 8LiuW.MorseJ.S.LalondeT.XuS.Learning from the past: possible urgent prevention and" exact="treatment" post="options for severe acute respiratory infections caused by 2019â€�nCoVChembiochem2020"/>
 <result pre="SARS coronavirus and MERS coronavirusâ€&quot;A possible reference for coronavirus diseaseâ€�19" exact="treatment" post="optionJ Med Virol202010.1002/jmv.25729 10MartinezM.A.Compounds with therapeutic potential against novel"/>
 <result pre="12YanD.LiuX-yZhuY-nFactors associated with prolonged viral shedding and impact of Lopinavir/Ritonavir" exact="treatment" post="in patients with SARS-CoV-2 infectionMedrxiv202010.1101/2020.03.22.20040832 13CaiQ.HuangD.OuP.COVIDâ€�19 in a designated"/>
 <result pre="compared to standard of care treatmentClinicalTrials.gov Identifier: NCT042927302020Accessed onhttps://www.clinicaltrials.gov/ct2/show/NCT04292730 23CaiQ.YangM.LiuD.Experimental" exact="treatment" post="with favipiravir for COVID-19: an open-label control studyEngineering2020 24ChenC.HuangJ.ChengZ.Favipiravir"/>
 <result pre="a 15-membered macrolide antibiotic, inhibits influenza A (H1N1) pdm09 virus" exact="infection" post="by interfering with virus internalization processJ Antibiot (Tokyo)72102019 Oct75976831300721"/>
 <result pre="U S A113502016 Dec 13144081441327911847 27LiC.ZuS.DengY.-Q.Azithromycin protects against zika virus" exact="infection" post="by upregulating virus-induced type I and III interferon responsesAntimicrob"/>
 <result pre="responsesAntimicrob Agents Chemother63122019 Sep 16e00394-19 28LeeN.WongC.-K.ChanM.C.Anti-inflammatory effects of adjunctive macrolide" exact="treatment" post="in adults hospitalized with influenza: a randomized controlled trialAntivir"/>
 <result pre="efficacy of oseltamivir-azithromycin combination therapy in prevention of influenza-a (H1N1)" exact="infection" post="complications and rapidity of symptom reliefExpert Rev Respir Med1452020"/>
 <result pre="and projection of optimized dosing design of hydroxychloroquine for the" exact="treatment" post="of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Clin Infect"/>
 <result pre="(2019-nCoV) in vitroCell Res3032020 Mar26927132020029 36GautretP.LagierJ.-C.ParolaP.Hydroxychloroquine and azithromycin as a" exact="treatment" post="of COVID-19: results of an open-label non-randomized clinical trialInt"/>
 <result pre="review on the efficacy and safety of chloroquine for the" exact="treatment" post="of COVID-19J Crit CareS0883â€&quot;9441202020 Mar 103039030397 39Chen JunL.D.LiuLiLiuPingXuA pilot"/>
 <result pre="CareS0883â€&quot;9441202020 Mar 103039030397 39Chen JunL.D.LiuLiLiuPingXuA pilot study of hydroxychloroquine in" exact="treatment" post="of patients with common coronavirus disease-19 (COVID-19)J Zhejiang Univ"/>
 <result pre="of clinical efficacy of hydroxychloroquine in patients hospitalized for COVID-19" exact="infection" post="with oxygen requirement: results of a study using routinely"/>
 <result pre="novel coronavirus pneumonia (COVID-19) patients who are still positive on" exact="virus detection" post="under the current antiviral therapyChiCTR2000029544, Accessed onhttp://www.chictr.org.cn/showprojen.aspx?proj=490132020 57A randomized,"/>
 <result pre="coronavirus pneumonia (COVID-19) patients who are still positive on virus" exact="detection" post="under the current antiviral therapyChiCTR2000029544, Accessed onhttp://www.chictr.org.cn/showprojen.aspx?proj=490132020 57A randomized,"/>
</results>
